C
Clinical Microbiomics
An independent contract research organization fully dedicated to microbiome research
About Clinical Microbiomics
Clinical Microbiomics is a contract research organization based in Copenhagen, Denmark, that specializes in microbiome and metabolome analysis. The company operates in the global microbiome science market, serving clients who require detailed and precise interpretations of biological data. Their clients typically include research institutions, pharmaceutical companies, and other organizations involved in biological and medical research.
The company's business model revolves around providing research services using an interdisciplinary approach. They combine biological and bioinformatic tools to analyze complex biological data, and they have a unique ability to innovate new analytical techniques and approaches. This integrated multi-omics approach ensures they provide a comprehensive analysis, enabling precise interpretations for their clients.
One of their key offerings is CHAMP™, a tool built from over 400,000 metagenome-assembled genomes (MAGs), created using a collection of more than 30,000 microbiome samples. This tool allows them to provide detailed and accurate analysis of microbiomes, which are the collection of all microorganisms in a particular environment, such as the human body.
Clinical Microbiomics generates revenue by charging clients for their research and analysis services. The pricing likely varies depending on the complexity and scope of the research question, the amount of data to be analyzed, and the level of precision required in the interpretation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Copenhagen, Denmark
- Employees
- 112
- Open positions
- None listed
- Dealroom signal
- 84.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Analytics, Biotechnology, Microbiology, Spinout, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 4 companies, latest Mar 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGER✓Other financing | Oct 2023 | $0 | — | CosmosID · MS-OMICS | ↗ |
| EARLY VC✓Equity / VC | Oct 2022 | $11M | $44M | Seventure Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Clinical Microbiomics is 40 monthly website visits, down 76.5% over the last three months. Clinical Microbiomics's team grew 5.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
DNASenseAalborg, DenmarkDNA data analysis app allows to dig into data, and interactively visualise it in different ways without having to know anything about complex data analysis software
→
MS-OMICSVedbæk, DenmarkMS-Omics - Your metabolomics service experts
→
CosmosIDRockville, United StatesCosmosID Metagenomics - Exploring the Universe of Microbes
$24Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Seventure Partners
Other known investors4 additional known investors
CosmosID
MS-OMICS
Technical University of Denmark- CMCMC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Clinical Microbiomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Clinical Microbiomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







